Re: "98d DMPA cycle" source needed; N so far

From: R. Daniel Braun, M.D. (rbraun@iunet.iupui.edu)
Wed Feb 18 07:47:58 1998


I find it interesting that Fotherby found reumption of "Luteal" function as early as 66 days, but no evidence of "Follicular" function before 104 days. I thought a follicle was necessary to lead to Luteal function. Or is this a typo? Dan -----Original Message----- From: Tessler <tessler@frontiernet.net> To: Multiple recipients of list <ob-gyn-l@talk.obgyn.net> Date: Tuesday, February 17, 1998 11:36 PM Subject: "98d DMPA cycle" source needed; N so far

>
>Fortherby et al. measured plasma estradiol and progesterone as indicators
>of resumption of follicular and luteal activity. Only five (5) women were
>tested after a 150 mg DMPA dose. The ranges in these women were 66 to over
>167 days for resumption of luteal function, and 104 to over 167 days for
>resumption of follicular function. The authors noted that these results
>were preliminary, and referred to a 90 day cycle for reinjection as the
>standard.
>
>Fotherby et al. led me to Kirton, K.T. and Cornette, J.C. (1974). Return of
>ovulatory cyclicity following an intramuscular injection of
>medroxyprogesterone acetate. Contraception, 10, 39-45. Three (3) women were
>included in this study, which showed that DMPA 150 mg "inhibited formation
>of a functional corpus luteum for a prolonged (>= 200 d) period of time."
>
>I also found Ortiz, A. et al.'s Serum medroxyprogesterone acetate (MPA)
>concentrations and ovarian function following intramuscular injection of
>Depo-MPA. (...I lost the source...I believe this article was in
>Contraception volume 2 or 1970). This study also followed three (3) women
>after a single DMPA injection until hormone levels demonstrated the first
>ovulatory cycle, which happened between seven and nine months after
injection. >
>The trail ended there, and a Medline search on {medroxyprogesterone and
>(fertility or ovulation)} yielded no additional studies. DMPA's
>manufacturer says they only have data on the 91 day schedule.
>
>So, I found some preliminary evidence to support a 98 day reinjection
>schedule; however, these three studies taken together looked at only eleven
>women. What I can't locate, and what I believe Dr. Kaunitz, Dr.
>Sanchez-Ramos, or others of you supporting the regimen must have read at
>some point, is a study with enough statistical power to suggest that 98
>days is a viable schedule for reliable pregnancy prevention in the
>overwhelming majority of women. If anyone has a recollection of a partial
>title or possible source of such a study, I'd appreciate any leads that
>might help me locate it.
>
>Patti Tessler, RN, Family Nurse Practitioner
>Orange County, New York, USA
>tessler@frontiernet.net
>
>Dr. Sanchez-Ramos wrote:
>>The "crazy assertion that one may inject DMPA 98 days after the last
>>injection..." can be documented by reading the article by Kaunitz AM.
>>"Long-acting injectable contraception with depot medroxyprogesterone
>>acetate" Am J Obstet Gynecol 1994;170:1543-9.
>>
>>Another reference on the same assertion: Fotherby K. Contraception
>>1980;22:527-36.
>>
>>The company may state that ovulation can occur once 91 days have passed
>>after the last dose but the data show that 98 days may be more than
>>appropriate.
>





use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Wed Dec 2 05:23:21 2009

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.